These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29681905)

  • 41. IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology.
    Wei HX; Wang B; Li B
    Front Immunol; 2020; 11():1315. PubMed ID: 32670290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
    Ge Y; Huang M; Yao YM
    Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-24 Immunobiology and Its Roles in Inflammatory Diseases.
    Zhong Y; Zhang X; Chong W
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-21 (IL-21) controls inflammatory pathways in the gut.
    Fina D; Caruso R; Pallone F; Monteleone G
    Endocr Metab Immune Disord Drug Targets; 2007 Dec; 7(4):288-91. PubMed ID: 18220949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases.
    Kasashima S; Kawashima A; Kasashima F; Endo M; Matsumoto Y; Kawakami K
    Heart Vessels; 2018 Dec; 33(12):1471-1481. PubMed ID: 29931542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-33/ST2 axis in inflammation and immunopathology.
    Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
    Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokines and their role in cardiovascular diseases.
    Haybar H; Bandar B; Torfi E; Mohebbi A; Saki N
    Cytokine; 2023 Sep; 169():156261. PubMed ID: 37413877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases.
    Hofmann MA; Kiecker F; Zuberbier T
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):451-7. PubMed ID: 27490126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
    Lin J; Zhang L; Zhao G; Su Z; Deng R; Pflugfelder SC; Li DQ
    PLoS One; 2013; 8(4):e60963. PubMed ID: 23585867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin 27: a double-edged sword for offense and defense.
    Yoshida H; Nakaya M; Miyazaki Y
    J Leukoc Biol; 2009 Dec; 86(6):1295-303. PubMed ID: 19801497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-29 Accelerates Vascular Calcification via JAK2/STAT3/BMP2 Signaling.
    Hao N; Zhou Z; Zhang F; Li Y; Hu R; Zou J; Zheng R; Wang L; Xu L; Tan W; Li C; Wang F
    J Am Heart Assoc; 2023 Jan; 12(1):e027222. PubMed ID: 36537334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease.
    Rizvi M; Pathak D; Freedman JE; Chakrabarti S
    Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
    Sun L; He C; Nair L; Yeung J; Egwuagu CE
    Cytokine; 2015 Oct; 75(2):249-55. PubMed ID: 25796985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.
    Ballak DB; Stienstra R; Tack CJ; Dinarello CA; van Diepen JA
    Cytokine; 2015 Oct; 75(2):280-90. PubMed ID: 26194067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-22 in human inflammatory diseases and viral infections.
    Shabgah AG; Navashenaq JG; Shabgah OG; Mohammadi H; Sahebkar A
    Autoimmun Rev; 2017 Dec; 16(12):1209-1218. PubMed ID: 29037907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD40 ligand: a neo-inflammatory molecule in vascular diseases.
    Hassan GS; Merhi Y; Mourad W
    Immunobiology; 2012 May; 217(5):521-32. PubMed ID: 21529993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging role of IL-35 in inflammatory autoimmune diseases.
    Su LC; Liu XY; Huang AF; Xu WD
    Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
    Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K
    Circ Res; 2012 Oct; 111(10):1274-85. PubMed ID: 22927332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.